Loading clinical trials...
Loading clinical trials...
This randomized, double-blind, multi-center, parallel-group study will evaluate the sustained virologic response and the safety of mericitabine (RO5024048) (MCB) in combination with telaprevir (TVR) a...
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
Hoffmann-La Roche
NCT06953479 · HEPATITIS C (HCV), Incarceration, and more
NCT04162938 · Hepatitis C
NCT03135886 · HIV/AIDS, Hepatitis C, and more
NCT05968573 · Human Immunodeficiency Virus (HIV), Hepatitis C (HCV)
NCT01644903 · Liver Transplant, Hepatitis C, and more
Birmingham Gastro Associates, P.C.
Birmingham, Alabama
VA Long Beach Healthcare System
Long Beach, California
Kaiser Permanente Sacramento Medical Center
Sacramento, California
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions